Cargando…

Prognostic and Predictive Biomarkers in Gliomas

Gliomas are the most common central nervous system tumors. New technologies, including genetic research and advanced statistical methods, revolutionize the therapeutic approach to the patient and reveal new points of treatment options. Moreover, the 2021 World Health Organization Classification of T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Śledzińska, Paulina, Bebyn, Marek G., Furtak, Jacek, Kowalewski, Janusz, Lewandowska, Marzena A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508830/ https://www.ncbi.nlm.nih.gov/pubmed/34638714 http://dx.doi.org/10.3390/ijms221910373

Ejemplares similares

Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics
por: Śledzińska, Paulina, et al.
Publicado: (2022)

Infratentorial Stereotactic Biopsy of Brainstem and Cerebellar Lesions
por: Furtak, Jacek, et al.
Publicado: (2021)

Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
por: Koper, Agnieszka, et al.
Publicado: (2023)

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
por: Szylberg, Mateusz, et al.
Publicado: (2022)

Prognostic and Predictive Epigenetic Biomarkers in Oncology
por: Kamińska, Katarzyna, et al.
Publicado: (2018)

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
por: Lewandowska, Marzena Anna, et al.
Publicado: (2013)

Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions
por: Roszkowski, Krzysztof, et al.
Publicado: (2016)

Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
por: Nalejska, Ewelina, et al.
Publicado: (2014)

IDH1 mutation analysis – an example of putative glioma marker
por: Lewandowska, Marzena, et al.
Publicado: (2012)

Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors
por: Chrzanowska, Natalia Magdalena, et al.
Publicado: (2020)

Metabolomic Phenotyping of Gliomas: What Can We Get with Simplified Protocol for Intact Tissue Analysis?
por: Goryńska, Paulina Zofia, et al.
Publicado: (2022)

Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME)
por: Bogusiewicz, Joanna, et al.
Publicado: (2021)

Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients
por: LEWANDOWSKA, MARZENA ANNA, et al.
Publicado: (2013)

Glioma Biopsy Based on Hybrid Dual Time-Point FET-PET/MRI—A Proof of Concept Study
por: Furtak, Jacek, et al.
Publicado: (2021)

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer
por: Czubak, Karol, et al.
Publicado: (2015)

Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
por: Baj, Jacek, et al.
Publicado: (2022)

Differential gene methylation patterns in cancerous and non-cancerous cells
por: Kamińska, Katarzyna, et al.
Publicado: (2019)

Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma
por: Harat, Maciej, et al.
Publicado: (2023)

A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy
por: Berbecka, Monika, et al.
Publicado: (2021)

BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing
por: Szczerba, Ewelina, et al.
Publicado: (2021)

The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer
por: Lewandowska, Marzena Anna, et al.
Publicado: (2015)

Chromosome Conformation Capture Reveals Two Elements That Interact with the PTBP3 (ROD1) Transcription Start Site
por: Kubiak, Marta, et al.
Publicado: (2019)

Recent developments in predictive biomarkers of pediatric glioma
por: Li, Zhengwei, et al.
Publicado: (2017)

Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
por: Haynes, Harry R., et al.
Publicado: (2014)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
por: vom Berg, Johannes, et al.
Publicado: (2013)

Stanniocalcin 1 is a prognostic biomarker in glioma
por: Luo, Weijian, et al.
Publicado: (2020)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Cryptographic Keys Generating and Renewing System for IoT Network Nodes—A Concept
por: Furtak, Janusz
Publicado: (2020)

The Cryptographic Key Distribution System for IoT Systems in the MQTT Environment
por: Furtak, Janusz
Publicado: (2023)

The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2022)

The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET
por: Malkowski, Bogdan, et al.
Publicado: (2015)

Reimbursement decision-making system in Poland systematically compared to other countries
por: Mela, Aneta, et al.
Publicado: (2023)

Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
por: Hasanau, Tsimur, et al.
Publicado: (2022)

Influence of Epilepsy on the Quality of Life of Patients with Brain Tumors
por: Krajewski, Stanisław, et al.
Publicado: (2021)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

Coated Blade Spray-Mass Spectrometry as a New Approach for the Rapid Characterization of Brain Tumors
por: Bogusiewicz, Joanna, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Increased Expression of Homeobox 5 Predicts Poor Prognosis: A Potential Prognostic Biomarker for Glioma
por: Xu, Chengran, et al.
Publicado: (2022)

LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma
por: Ma, Wenping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ioh65uq06kvcakr1urvs506fac